Who Paid My Doc
Foundationone CDX
Device Oncology
General payments
$4,811,594
Research payments
$1,114,100
Through program year 2023, $4,811,594 in general payments and $1,114,100 in research payments were reported against Foundationone CDX (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $565,765 | 669 |
| 2023 | Research | $75,000 | 2 |
| 2022 | General | $976,704 | 2,449 |
| 2022 | Research | $107,500 | 2 |
| 2021 | General | $1,025,322 | 1,960 |
| 2021 | Research | $329,500 | 23 |
| 2020 | General | $1,129,226 | 2,055 |
| 2020 | Research | $602,100 | 4 |
| 2019 | General | $1,114,576 | 2,953 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 38 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
10,086 general · 31 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.